{"id":21445,"date":"2013-05-29T14:57:15","date_gmt":"2013-05-29T14:57:15","guid":{"rendered":"http:\/\/i-base.info\/htb\/?p=21445"},"modified":"2013-05-29T22:44:07","modified_gmt":"2013-05-29T22:44:07","slug":"eu-approves-four-in-one-stribild","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/21445","title":{"rendered":"EU approves four-in-one Stribild"},"content":{"rendered":"<p><strong>STOP\u00a0PRESS:\u00a0On\u00a028\u00a0May\u00a02013,\u00a0Gilead\u00a0announced\u00a0that\u00a0the\u00a0European\u00a0Commission\u00a0has\u00a0granted\u00a0market\u00a0authorisation\u00a0for\u00a0Stribild\u00a0with\u00a0an\u00a0indication\u00a0for\u00a0treatment-naive\u00a0patients.\u00a0<\/strong><\/p>\n<p>This\u00a0is\u00a0a\u00a0single\u00a0tablet\u00a0combination\u00a0containing\u00a0elvitegravir\u00a0150\u00a0mg\/cobicistat\u00a0150\u00a0mg\/FTC\u00a0200\u00a0mg\/tenofovir\u00a0DF\u00a0245\u00a0mg.<\/p>\n<p>Ref:\u00a0Gilead\u00a0press\u00a0statement.\u00a0European\u00a0Commission\u00a0approve\u00a0Stribild,\u00a0a\u00a0new\u00a0single\u00a0tablet\u00a0regimen\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0HIV-1\u00a0infection.\u00a0(28\u00a0May\u00a02013).<\/p>\n<p><a href=\"http:\/\/www.gilead.com\/news\/press-releases\">http:\/\/www.gilead.com\/news\/press-releases<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>STOP\u00a0PRESS:\u00a0On\u00a028\u00a0May\u00a02013,\u00a0Gilead\u00a0announced\u00a0that\u00a0the\u00a0European\u00a0Commission\u00a0has\u00a0granted\u00a0market\u00a0authorisation\u00a0for\u00a0Stribild\u00a0with\u00a0an\u00a0indication\u00a0for\u00a0treatment-naive\u00a0patients.\u00a0 This\u00a0is\u00a0a\u00a0single\u00a0tablet\u00a0combination\u00a0containing\u00a0elvitegravir\u00a0150\u00a0mg\/cobicistat\u00a0150\u00a0mg\/FTC\u00a0200\u00a0mg\/tenofovir\u00a0DF\u00a0245\u00a0mg. Ref:\u00a0Gilead\u00a0press\u00a0statement.\u00a0European\u00a0Commission\u00a0approve\u00a0Stribild,\u00a0a\u00a0new\u00a0single\u00a0tablet\u00a0regimen\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0HIV-1\u00a0infection.\u00a0(28\u00a0May\u00a02013). http:\/\/www.gilead.com\/news\/press-releases<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-21445","post","type-post","status-publish","format-standard","hentry","category-antiretrovirals"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/21445","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=21445"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/21445\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=21445"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=21445"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=21445"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}